QQ客服 官方微博 反馈留言

	Efficacy and safety of 1-hour infusion of recombinant human atrial natriuretic peptide in patients with acute decompensated heart failure: a phase III, randomized, double-blind, placebo-controlled, multicenter trial
	Wang, Pengbo; Wang, Guo-Gan; Li, Yi-Shi; Liu, Wen-Xian; Bai, Shu-Gong; Zhen, Yang; Li, Dong-Ye; Yang, Ping; Hong, Lang; Sun, Jian-Hui
	2015
卷号	66期号:16页码:C208-C208
ISSN号	0735-1097
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6386946
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Wang, Pengbo,Wang, Guo-Gan,Li, Yi-Shi,et al. Efficacy and safety of 1-hour infusion of recombinant human atrial natriuretic peptide in patients with acute decompensated heart failure: a phase III, randomized, double-blind, placebo-controlled, multicenter trial[J],2015,66(16):C208-C208.
APA	Wang, Pengbo.,Wang, Guo-Gan.,Li, Yi-Shi.,Liu, Wen-Xian.,Bai, Shu-Gong.,...&Wang, Si-Jia.(2015).Efficacy and safety of 1-hour infusion of recombinant human atrial natriuretic peptide in patients with acute decompensated heart failure: a phase III, randomized, double-blind, placebo-controlled, multicenter trial.,66(16),C208-C208.
MLA	Wang, Pengbo,et al."Efficacy and safety of 1-hour infusion of recombinant human atrial natriuretic peptide in patients with acute decompensated heart failure: a phase III, randomized, double-blind, placebo-controlled, multicenter trial".66.16(2015):C208-C208.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。